You are here

Article metrics

Article menu

Download PDFPDF

Poster Presentation
Indoleamine 2,3-dioxygenase is a critical resistance mechanism in anti-tumor T cell immunotherapy targeting CTLA-4

 

Online download statistics by month:

Online download statistics by month: December 2019 to July 2025

AbstractFullPdf
Dec 2019010
Jan 2020031
Feb 2020031
Mar 2020010
Apr 2020011
May 20200100
Jun 202002020
Jul 2020030
Aug 2020030
Sep 2020090
Oct 2020010
Nov 2020010
Dec 2020031
Jan 2021020
Feb 2021011
Mar 2021020
Apr 2021051
May 2021030
Jun 2021051
Jul 2021050
Aug 2021020
Sep 2021011
Oct 2021011
Nov 2021033
Dec 2021050
Jan 2022050
Feb 2022040
Mar 2022031
Apr 2022091
May 20220180
Jun 20220152
Jul 2022091
Aug 2022062
Sep 2022090
Oct 2022092
Nov 20220158
Dec 2022030
Jan 2023050
Feb 20230200
Mar 2023032
Jun 2023011
Jul 2023011
Aug 2023010
Sep 2023030
Oct 2023003
Nov 2023041
Dec 2023071
Jan 2024071
Feb 2024041
Mar 20240530
Apr 20240910
May 2024042
Jun 20240101
Jul 20240101
Aug 2024051
Sep 20240124
Oct 2024083
Nov 2024091
Dec 2024032
Jan 2025067
Feb 2025072
Mar 2025044
Apr 20250246
May 2025063
Jun 20250134
Jul 2025010
Total0573121